Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study
Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study
Yükleniyor...
Abstract
Description
Fields of Science
03 medical and health sciences, 0302 clinical medicine
Citation
WoS Q
Scopus Q
Source
Volume
33
Issue
6
Start Page
365
End Page
Yükleniyor...